Stratasys machines get validated by Materialise for 3D printed patient-specific anatomical models

Belgium-based additive manufacturing company, Materialise, has announced that they have validated Stratasys 3D printers and materials for the manufacturing of patient-specific anatomical models when used in tandem with FDA-approved Mimics inPrint software, and represent a huge step towards unlocking the potential of this technology for improved patient care.

The validation pairs Materialise’s FDA-approved Mimics inPrint software together with the most versatile 3D printing systems from Stratasys, and advance point-of-care for patients. The Mimics inPrint software received FDA clearance in March 2018, and 16 of the top 20 hospitals in America now uses it for the printing of 3D printed anatomical models.

Model of patient's left atrial appendage (LAA) that allows surgeons to select the appropriate device and plan the optimal approach to occlude the LAA. — Model of patient’s left atrial appendage (LAA) that allows surgeons to select the appropriate device and plan the optimal approach to occlude the LAA.

With the validation through Materialise’s certification process, doctors and hospitals can now enjoy improved access to high-quality anatomical models to provide personalized care to patients.

Specifically, Stratasys’s PolyJet multi-material and multi-color 3D printing solutions, the J750, J735, and the high-performance desktop Objet30 Prime 3D printers can now work hand-in-hand with Materialise Mimics inPrint, to offer more trusted and reliable surgical planning and improve communication.

3D printed anatomical head model printed with J750 — 3D printed anatomical head model printed with Stratasys J750.

The versatility of Stratasys’s machines allows support for most complex cases across a wide range of surgical specialties on a single printer, regardless of whether it’s printing a model for mimicking human tissues or for medical centers seeking a good entry-level option.

Historically, pre-surgical planning involved 2D imaging where physicians had to mentally reconstruct the patient’s anatomy. 3D printing manages to evolve this approach by digitally producing precise replicas of patient’s anatomy, and better visualize a patient’s condition before any operations.

J750 3D printer is validated with the Materialise FDA-cleared software, with a selection of 8 different materials — 8 different multi-color/material and biocompatible materials for the J750 are now validated with the Materialise FDA-cleared software.

As usage of 3D printers continues to increase across hospitals for better diagnostics and improved care of patients, this validation from Materialise will further power anatomical modeling while relieving any safety and quality burdens for healthcare providers.

Source: creatz3d.com.sg